evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract
15587,GENE_SUMMARY,,"MSH3, a protein that participates in mismatch DNA repair pathway, is frequently lost in colorectal cancers.",,2017-07-29,,4437,MSH3,mutS homolog 3,False,ENST00000265081,NM_002439.4,MRP1,DUP,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
15588,GENE_BACKGROUND,,"MSH3 encodes the protein MutS Homolog 3 (MSH3) ,the human homolog of the bacterial MutS protein, which functions in the mismatch repair (MMR) pathway of DNA repair. MSH3 partners with MSH2 to form the heterodimer MutS-beta, which is important for recognition and repair of mismatched base pairs, forming a DNA-MutS complex which signals other components of the MMR machinery to excise the aberrant nucleotide (PMID: 22179786, 8942985, 9679053). MSH3 deletion or loss-of-function mutations can result in MMR deficiency, leading to an increased mutation rate. MSH3 is altered in nearly 50% of MMR-deficient colorectal cancers by somatic frameshift mutations (PMID: 23724141,18922920,14871813, 9331106). Tumors with a large number of somatic mutations due to mismatch-repair defects have been predictive of clinical benefit to certain immune checkpoint blockade therapies (PMID: 26028255, 25409260). Recently, the FDA approved pembrolizumab (PD-1 blockade) for all mismatch repair deficient and microsatellite unstable (MSI-high) tumors, irrespective of specific tumor etiology.",,2017-08-01,,4437,MSH3,mutS homolog 3,False,ENST00000265081,NM_002439.4,MRP1,DUP,False,9331106,Frameshift somatic mutations in gastrointestinal cancer of the microsatellite mutator phenotype.,Cancer research,0001-10-01,57,19,4420-6,Yamamoto H et al,,,0001-10-01,,22179786,Mechanism of mismatch recognition revealed by human MutSÎ² bound to unpaired DNA loops.,Nature structural &amp; molecular biology,2017-12-18T20:11:00,19,True,1972-08-01,Gupta S et al,doi: 10.1038/nsmb.2175,,0001-12-18,,23724141,MSH3 mismatch repair protein regulates sensitivity to cytotoxic drugs and a histone deacetylase inhibitor in human colon carcinoma cells.,PloS one,2013,8,5,e65369,Park JM et al,doi: 10.1371/journal.pone.0065369,,Park JM et al. PloS one. 2013;8(5)e65369.,,25409260,Genetic basis for clinical response to CTLA-4 blockade in melanoma.,The New England journal of medicine,2017-12-04T20:14:00,371,23,2189-2199,Snyder A et al,doi: 10.1056/NEJMoa1406498,,0001-12-04,,18922920,Genetic instability caused by loss of MutS homologue 3 in human colorectal cancer.,Cancer research,2018-10-15T20:08:00,68,20,8465-72,Haugen AC et al,doi: 10.1158/0008-5472.CAN-08-0002,,0001-10-15,,8942985,hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6.,Proceedings of the National Academy of Sciences of the United States of America,0001-11-26,93,24,13629-34,Acharya S et al,,,0001-11-26,,14871813,Loss of MSH3 protein expression is frequent in MLH1-deficient colorectal cancer and is associated with disease progression.,Cancer research,2018-02-01T20:04:00,64,3,864-70,Plaschke J et al,,,0001-02-01,,26028255,PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.,The New England journal of medicine,2018-06-25T20:15:00,372,26,2509-20,Le DT et al,doi: 10.1056/NEJMoa1500596,,0001-06-25,,9679053,"Mismatch repair, molecular switches, and signal transduction.",Genes &amp; development,0001-07-15,12,14,2096-101,Fishel R,,,2018-07-15T01:01:00,
